1. Home
  2. LGN vs MANE Comparison

LGN vs MANE Comparison

Compare LGN & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legence Corp.

LGN

Legence Corp.

N/A

Current Price

$54.05

Market Cap

4.5B

Sector

N/A

ML Signal

N/A

Logo Veradermics Incorporated Common Stock

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$97.02

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGN
MANE
Founded
1963
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.3B
IPO Year
2025
2026

Fundamental Metrics

Financial Performance
Metric
LGN
MANE
Price
$54.05
$97.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
4
Target Price
$59.50
$83.33
AVG Volume (30 Days)
1.1M
771.8K
Earning Date
05-15-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,550,491,000.00
N/A
Revenue This Year
$53.66
N/A
Revenue Next Year
$11.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.53
N/A
52 Week Low
$28.31
$36.26
52 Week High
$107.24
$131.24

Technical Indicators

Market Signals
Indicator
LGN
MANE
Relative Strength Index (RSI) 37.53 42.27
Support Level $42.97 $91.62
Resistance Level $58.00 $116.86
Average True Range (ATR) 3.45 5.50
MACD -0.38 -0.85
Stochastic Oscillator 2.85 29.76

Price Performance

Historical Comparison
LGN
MANE

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation, and maintenance services for critical systems in buildings. It focuses on sectors that have technically demanding buildings, including technology, life sciences, healthcare, and education. Legence specializes in designing, fabricating, and installing complex heating, ventilation, and air conditioning (HVAC), process piping, and other mechanical, electrical, and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting, and building controls in existing facilities to enhance building performance, reliability, and efficiency. The services are mainly provided on a fixed price basis. The company has two reportable segments: Installation and Maintenance, which generates the maximum revenue, and Engineering and Consulting.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: